Literature DB >> 8482450

Calretinin and calbindin-D28k immunoreactivity in the human gastrointestinal tract.

J R Walters1, A E Bishop, P Facer, E M Lawson, J H Rogers, J M Polak.   

Abstract

BACKGROUND: Calretinin and calbindin-D28k are similar Ca(2+)-binding proteins previously described in specific central neurons and other cells.
METHODS: The immunocytochemical distribution of these two proteins was studied in the human gastrointestinal tract.
RESULTS: In gastric and small intestinal endocrine cells, calbindin-D28k immunoreactivity was confirmed, but calretinin immunoreactivity was not found. Nerve cell bodies in both submucous and myenteric ganglia were immunoreactive for calbindin (13% and 38% of total cells, respectively) or calretinin (23% and 21%), some containing both proteins. In nerve processes, calretinin was generally more abundant than calbindin and was found particularly around blood vessels. Calretinin co-localized with immunoreactive vasoactive intestinal peptide, neuropeptide Y, galanin, or substance P in submucous ganglion cells and with substance P in myenteric cells. Calbindin-D28k colocalized with fewer peptides, specifically vasoactive intestinal peptide or galanin in submucous cells. By 8 weeks of fetal development, discrete neuronal localizations for both proteins and for calbindin-D28k in endocrine cells were apparent.
CONCLUSIONS: In the enteric neuroendocrine system, calretinin and calbindin-D28k are useful markers that may help elucidate Ca(2+)-mediated functions in health and disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8482450     DOI: 10.1016/0016-5085(93)90346-e

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  10 in total

1.  Cholinergic and nitrergic interneurones in the myenteric plexus of the human colon.

Authors:  A J Porter; D A Wattchow; S J H Brookes; M Costa
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

2.  What neurons hide behind calretinin immunoreactivity in the human gut?

Authors:  Nicholas Beuscher; Samir Jabari; Johanna Strehl; Winfried Neuhuber; Axel Brehmer
Journal:  Histochem Cell Biol       Date:  2013-11-08       Impact factor: 4.304

3.  Quadruple colocalization of calretinin, calcitonin gene-related peptide, vasoactive intestinal peptide, and substance P in fibers within the villi of the rat intestine.

Authors:  K R Isaacs; L Winsky; K I Strauss; D M Jacobowitz
Journal:  Cell Tissue Res       Date:  1995-06       Impact factor: 5.249

4.  Calretinin immunoreactivity in human sympathetic ganglia.

Authors:  J J Huerta; S Nori; M M Llamosas; M T Vázquez; E Bronzetti; J A Vega
Journal:  Anat Embryol (Berl)       Date:  1996-10

5.  Distribution and colocalization of nitric oxide synthase and calretinin in myenteric neurons of developing, aging, and Crohn's disease human small intestine.

Authors:  A Belai; G Burnstock
Journal:  Dig Dis Sci       Date:  1999-08       Impact factor: 3.199

6.  A critical appraisal of the morphological criteria for diagnosing intestinal neuronal dysplasia type B.

Authors:  Simone A Terra; Pedro L de Arruda Lourenção; Márcia G Silva; Hélio A Miot; Maria A M Rodrigues
Journal:  Mod Pathol       Date:  2017-03-17       Impact factor: 7.842

7.  The loss of calretinin expression indicates aganglionosis in Hirschsprung's disease.

Authors:  I Barshack; E Fridman; I Goldberg; Y Chowers; J Kopolovic
Journal:  J Clin Pathol       Date:  2004-07       Impact factor: 3.411

8.  Secretoneurin: a new peptide in the human enteric nervous system.

Authors:  G Schürmann; A E Bishop; P Facer; U Eder; R Fischer-Colbrie; H Winkler; J M Polak
Journal:  Histochem Cell Biol       Date:  1995-07       Impact factor: 4.304

9.  Calbindin D28k-Immunoreactivity in Human Enteric Neurons.

Authors:  Katharina Zetzmann; Johanna Strehl; Carol Geppert; Stefanie Kuerten; Samir Jabari; Axel Brehmer
Journal:  Int J Mol Sci       Date:  2018-01-08       Impact factor: 5.923

Review 10.  Development of enteric neuron diversity.

Authors:  Marlene M Hao; Heather M Young
Journal:  J Cell Mol Med       Date:  2009-06-16       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.